Parthenon posts 90% IRR on med tech deal

Parthenon Capital has sold its controlling stake in Spheris, a US medical transcription business, to private equity groups Warburg Pincus and Soros Private Equity for an undisclosed amount.

ByPEI Staff

30 December 2012•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America

Parthenon posts 90% IRR on med tech deal

Parthenon Capital

Warburg Pincus

Related articles